Man who raised £100k for charity since cancer diagnosis to take on 588-mile walk
Mr Dennington, who has raised more than £100,000 and awareness for Prostate Cancer UK since his diagnosis in February 2021, wants to fund research and a screening programme to help others.
He said: 'When I was diagnosed it felt surreal as I didn't have symptoms and thought I was pretty fit and healthy. I did feel guilt, though, as it was my body that was the reason my family were going to have to go through this journey.
'When I started fundraising, I thought I might raise up to £5,000 but it kind of took off. It has become a great source of positive focus, and I've met so many wonderful and generous people along the way. For this challenge I wanted to do something different and big that would grab attention, would encourage donations, be physically challenging and would be personally poignant for my fifth year.
'With the amazing support of my wife in particular, family and friends, I want to raise awareness of the cancer, its risks, drive testing and raise valuable funds to support those going through this terrible experience, to create a screening programme and for vital research.
'I want to help prevent other men and their families from going through the same journey as mine and to give hope to those who already are.'
He will set off from his place of birth in North Shields on Sunday, and the opening day will see him visit his first house, his former infant and junior school and will end at St James' Park, home to his boyhood football club, Newcastle United.
As he navigates his way south, Mr Dennington will visit key life landmarks, and pay tribute at the resting places of his late parents.
Mr Dennington's challenge finishes on September 7 when he reaches his current home in Hempstead where he has lived for the past 27 years. By which time he would have also scaled 27,375 feet, just shy of the summit of Mount Everest.
The serious message of his walk will also be shared via several awareness talks along the way.
Mr Dennington added: 'Caught early, prostate cancer is very treatable. However, I'm one of the circa 10,000 men a year caught too late to be cured and did not have obvious symptoms.
'For me, without a screening programme in the UK we rely heavily on well-informed and willing men to proactively get themselves tested. That is why raising awareness of risk is so important.'
Prostate Cancer UK chief executive Laura Kerby said: 'We're so grateful for the fantastic support from Paul as he tirelessly walks 588 miles to raise funds and celebrate his life.
'To say Paul is a force of nature would be an understatement. Despite his diagnosis, he has worked relentlessly to raise funds and awareness for Prostate Cancer UK, and his efforts are always whole-hearted. It's fair to say this is his most extreme to date, and I know this is a deeply personal journey for Paul, and is one he will tackle with the same grit and determination he has approached the last four and a half years.'
Mr Dennington has already raised more than £16,000 before the challenge starts, and has set himself a target of £30,000. You can view his page at www.justgiving.com/team/paul-dennington-march-through-life-team-page.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
8 hours ago
- BBC News
Scunthorpe General Hospital patient died after power cut during surgery
A patient died following a "sudden failure of electrical power" during heart surgery, a coroner's report has Dye, 77, was undergoing a procedure at Scunthorpe General Hospital on 7 September to treat cardiac disease when the outage, which lasted 10 minutes, inquest into her death found it was likely she would have survived but for the loss of Lincolnshire senior coroner Paul Smith sent a Prevention of Future Deaths (POFD) report to NHS England, which the BBC has approached for comment. Ms Dye died as a result of a tear in the iatrogenic artery, the inquest into her death was loss of power happened when medical staff were about to deploy cardiac stents, with a "limited opportunity to provide the necessary remedial treatment", the inquest Emergency Power Off (EPO) circuit was then activated, which overrode the back up electrical supply and staff had to wait for an engineer to reset the circuit before gaining power was regained after 10 minutes when the stenting procedure was then complete but Mrs Dye failed to recover and was confirmed clear cause for the loss of power was identified, the inquest found. 'Critical factor' In his report, Mr Smith said: "Had staff been aware of the exact cause of the loss of power on this occasion and had they had the opportunity to reset the circuit without the need to await the arrival of an engineer, who in turn had to attend a separate plant room, the downtime would likely have been significantly reduced."The coroner noted that "the delay whilst power was restored was a critical factor in this death".The report has been sent to NHS England "inviting a review" into the guidance in relation to operating Emergency Power Off (EPO) circuit controls. Mr Smith also asked if there was a need for any consequential said he had "received evidence of a small number of accidental activations of EPO circuits nationally over a 12-month period"."It is plainly something which can, and does, occur," Mr Smith gave NHS England until 28 August to respond to the report with a "timetable for action". Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here. Download the BBC News app from the App Store for iPhone and iPad or Google Play for Android devices
Daily Mail
a day ago
- Daily Mail
Pensioner, 77, died during heart surgery when hospital suffered a ten-minute power cut during a crucial stage, inquest hears
A pensioner died during heart surgery at an NHS hospital after the operating theatre she was in suffered a ten-minute-long power cut, an inquest heard. Jean Dye, 77, was at the crucial stage of the procedure when the electricity went down - meaning doctors had to delay the process as they couldn't see vital X rays. Five years after her death, a coroner has now issued a report saying that the delay in restoring power was a 'critical factor in her death'. It was found that an engineer was required to reset the system because it was in another part of the hospital. In a Prevention of Future Deaths Report, Paul Smith, Senior Coroner for Greater Lincolnshire, has now raised concerns about the lack of power controls within the operating theatre and that medical professionals weren't trained in how to understand when electricity has been restored. Mrs Dye, from Grimsby, Lincolnshire, suffered an underlying cardiac disease and attended Scunthorpe General Hospital to have it treated, the inquest was told. At the time of her death in September, 2020, she was having stents implanted to treat narrowed blood vessels. The operation only has a limited window to deploy the devices, the hearing was told. However, at exactly this moment there was a 'sudden and unexpected' power cut, which lasted for 10 minutes. It meant that medics could not see X-rays they needed for the procedure. No clear cause for the power cut has been identified, other than it overrode the back-up electrical supply, Mr Smith said. It was confirmed that power cuts have occasionally happened at hospitals across the country but the staff in Scunthorpe had not had this happen before. There was no manual re-activation of the circuit meaning that an engineer had to come to fix the issue. Once the power had returned, the stenting was completed but Mrs Dye failed to recover and she later passed away, the inquest heard. The hearing concluded that 'on the balance of probabilities, Mrs Dye would have survived but for the loss of electrical power'. It gave her cause of death as an iatrogenic artery dissection during a percutaneous coronary intervention. Mr Smith raised concerns about the lack of an indicator within the lab to confirm that the power had re-activated. There were also issues with the reset button being elsewhere in the hospital. Mr Smith said: 'The delay whilst power was restored was a critical factor in this death. 'The loss of power arose as a result of the Emergency Power Off (EPO) circuit activating. It overrode the emergency power back up system. 'All staff at the scene were unaware of the cause of the loss of power, never having experienced such a situation previously, and an engineer was summoned to attend to reinstate the power, which he did. 'There was no light or other indicator within the lab to confirm to those present that the EPO circuit had activated. Likewise there was no restart button within the lab to permit the EPO circuit to be reset. That lay within the plant room elsewhere within the hospital. 'Had staff been aware of the exact cause of the loss of power on this occasion and had they had the opportunity to reset the circuit without the need to await the arrival of an engineer, who in turn had to attend a separate plant room, the downtime would likely have been significantly reduced. 'Whilst it was not possible to say that the additional time spent on this occasion made a difference between the patient surviving or not, there may well be future cases within which such fine margins are time critical. 'I received evidence that there is no current guidance in relation to the siting of such controls remote from the affected room. I invite review of that guidance and of the need for any consequential training.' Mr Smith sent the report to NHS England and the Health Service Executive, who have until August 28 to respond.
Scottish Sun
3 days ago
- Scottish Sun
Thousands of men given ‘unnecessary' cancer treatment every year due to ‘wild west' guidelines
A leading cancer charity says "enough is enough" as it calls for Nice to update its advice 'HARMFUL' Thousands of men given 'unnecessary' cancer treatment every year due to 'wild west' guidelines Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) UP to 5,000 men every could avoid unnecessary cancer treatment if "outdated" guidelines reflected latest evidence, a charity has urged. Overtreatment can lead to side effects such as erectile dysfunction or incontinence, it warned. Sign up for Scottish Sun newsletter Sign up 1 For men whose prostate cancer is unlikely to progress, experts suggest close monitoring is the "best" option - but advice on this hasn't been updated since 2021 Credit: Getty Prostate cancer is a leading cause of cancer deaths in males in the UK, with around 55,000 new cases diagnosed every year. However, in some cases, the cancer is slow-growing and unlikely to ever cause the patient harm. For men whose cancer is unlikely to progress, experts suggest close monitoring is the "best" option. However, out-of-date guidance from the National Institute of Health and Care Excellence (Nice) on how this is implemented has created a "wild west". Close monitoring involves blood tests and scans, known as active surveillance. Nice guidance on active surveillance is designed to advise specialists on how to implement monitoring and which men should be monitored. However, it hasn't been updated since 2021, according to Prostate Cancer UK. A Freedom of information (FOI) request analysis by the charity found around one in four (24 per cent) of hospitals rely on Nice guidance alone to implement active surveillance. It also found 35 hospitals have created their own guidelines, which Prostate Cancer UK warned can lead to inconsistency and confusion among medics. The charity is now repeating its call for Nice to update its guidance on active surveillance, claiming it could help up to 5,000 men a year avoid overtreatment. I thought I was drinking too much tea - but it was actually a deadly condition It also claims the outdated guidance is hindering a screening programme for prostate cancer. Amy Rylance, assistant director of health improvement at Prostate Cancer UK, said: "To reduce the harm caused by prostate cancer and build the foundations for a screening programme, we need to both save lives and prevent unnecessary treatment but official guidelines still haven't caught up with the clinical evidence. "Concerns about overtreatment are a major reason the UK does not routinely screen for prostate cancer, despite it being the most common cancer in England. "Acting on latest research that shows more men can safely opt for monitoring instead of treatment will reduce overtreatment and the harm it causes men. "We asked Nice to update their active surveillance guidance two years ago, but our request was rejected. Now we have evidence this is potentially affecting thousands of men. Enough is enough." Current testing for prostate cancer The NHS uses a prostate-specific antigen (PSA) blood test to check for prostate conditions, including prostate cancer or an enlarged prostate. Routine PSA testing is not currently offered on the NHS, but patients may be offered a PSA test if a GP suspects they have prostate cancer, while men over 50 can request a test from their GP even if they do not have symptoms. But there have been calls to roll the test out across the health service, although some argue widespread use could identify cases which may not have caused problems or needed treatment. Vincent Gnanapragasam, a professor of urology at the University of Cambridge, said: "Active surveillance is the best treatment option for men whose cancer is unlikely to progress or cause them problems in their lifetime. "But Nice's outdated guidelines have created a deeply concerning wild west on how surveillance is implemented by different healthcare teams. What is prostate cancer? Prostate cancer affects a small, walnut shaped gland that sits underneath the bladder and surrounds the urethra - the tube carrying pee outside the body. It usually grows bigger as you get older. The prostate's main job is to help make semen – the fluid that carries sperm. Most men with early prostate cancer don't have any signs or symptoms - that's why it's important to know about your risk. Possible symptoms include: Difficulty starting to urinate or emptying your bladder A weak flow when you urinate A feeling that your bladder hasn't emptied properly Dribbling urine after you finish urinating Needing to urinate more often than usual, especially at night A sudden need to urinate – you may sometimes leak urine before you get to the toilet If you do notice changes in the way you urinate, this is more likely to be a sign of an enlarged prostate, which is very common and non-cancerous. But it's still a good idea to get it checked out. In the UK, about one in eight men will be diagnosed with prostate cancer in their lifetime. Some factors may mean you're more likely to get it. This includes: Getting older – it mainly affects men aged 50 or over Having a family history of prostate cancer Being Black If you have any of these risk factors or if you have any symptoms, speak to your GP. They can talk to you about your risk, and about the tests that are used to diagnose prostate cancer. Source: Prostate Cancer UK "This inconsistency is resulting in a lack of confidence from patients in surveillance, who may instead opt to have treatment they may not have ever needed, risking harmful side effects. "Programmes for active surveillance that are standardised and individualised to a man's risk factors have been tested and proven to work." The UK's National Screening Committee is currently assessing whether a national screening programme for prostate cancer should be rolled out. A Nice spokesperson said: "We are committed to ensuring our guidelines continue to reflect the best available evidence and give patients the best possible outcomes. "They are developed by an independent committee, including NHS clinical experts, and are kept under review to ensure they remain current. "We are updating our prostate cancer guidelines, including a review of the recommendations around active surveillance, and will be assessing whether our suspected cancer guideline recommendations around age-related thresholds for PSA tests for prostate cancer for onwards referral from primary care require updating."
